Skip to content
Home/Companies/Pharma/Ascelia Pharma

Ascelia Pharma

Pharma·Sweden·Exited 2019·Held 11yr
Entry
2008
Hold
11yr
Exit
2019

Who owns Ascelia Pharma?

Ascelia Pharma was owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures III (2007 vintage) from 2008 to 2019, exited via IPO.

Hand-verified · updated 2026-08-18

Sunstone Life Science Ventures
Investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures III · 2007 · VC

Key facts

HQSweden
SectorPharma
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2019

More from Sunstone Life Science Ventures III

Other portfolio companies in the same fund.

MinervaX
MinervaX
Active
BiotechDenmark· 2014
Cantargia
Exited 2015
BiotechSweden· 2013
Opsona Therapeutics
Exited 2019
BiotechIreland· 2013
Follicum
Exited 2014
BiotechSweden· 2012
to
Galecto
Exited 2020
BiotechDenmark· 2012
Orphazyme
Orphazyme
Exited 2017
BiotechDenmark· 2011

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
Laboratoires Delbert
Active
SocadifFrance
Pharmathen
Active
Partners GroupGreece
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Biogaran
Biogaran
Active
Bpifrance InvestissementFrance· 2026
Track Ascelia Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Ascelia Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Ascelia Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue